G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort - Archive ouverte HAL Access content directly
Conference Papers Year : 2015

G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort

, (1) , , , , , , (2, 3) , , , , , , (4) , , , , , , , (5) , , ,
1
2
3
4
5
A. Coilly
  • Function : Author
V. de Ledinghen
  • Function : Author
P. Houssel-Debry
  • Function : Author
C. Duvoux
  • Function : Author
V. Di Martino
  • Function : Author
S. Radenne
  • Function : Author
L. D’alteroche
  • Function : Author
V. Leroy
  • Function : Author
V. Canva
  • Function : Author
P. Lebray
  • Function : Author
C. Moreno
  • Function : Author
C. Silvain
  • Function : Author
C. Besch
  • Function : Author
P. Perré
  • Function : Author
D. Botta-Fridlund
  • Function : Author
R. Anty
  • Function : Author
A. Rohel
  • Function : Author
H. Danjou
  • Function : Author
J. -C. Duclos-Vallee
  • Function : Author
G. -P Pageaux
  • Function : Author

Abstract

no abstract
Not file

Dates and versions

hal-01162709 , version 1 (11-06-2015)

Identifiers

Cite

A. Coilly, C. Fougerou, V. de Ledinghen, P. Houssel-Debry, C. Duvoux, et al.. G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort. The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S236--S237, ⟨10.1016/S0168-8278(15)30103-3⟩. ⟨hal-01162709⟩
105 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More